DC-induced CD8+ T-cell response is inhibited by MHC class II-dependent DX5+CD4+ Treg

European Journal of Immunology

Volumn 39, Issue 7, 2009, Pages 1765-1773

  Han, Wanda G H ^a   Schuurhuis, Danita H ^a,c   Fu, Nathalie ^a   Camps, Marce ^a   van Duivenvoorde, Leonie M ^a,d   Louis Plence, Pascale ^b   Franken, Kees L M C ^a   Huizinga, Tom W J ^a   Melief, Cornelis J M ^a   Toes, René E M ^a   Ossendorp, Ferry ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSERM   (France)

^c GENMAB   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

DC; Immune regulation; MHC; T cells

Indexed keywords

DENDRITIC CELL VACCINE; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTEGRIN ALPHA2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; VACCINATION;

EID: 69249084062     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838842     Document Type: Article

References (43)

1. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
2. Keene, J. A. and Forman, J., Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp. Med. 1982. 155: 768-782.
3. Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D. and Levitsky, H., The central role of CD4(+) T cells in the antitumor immune response. J. Exp. Med. 1998. 188: 2357-2368.
4. Guerder, S. and Matzinger, P., A fail-safe mechanism for maintaining self-tolerance. J. Exp. Med. 1992. 176: 553-564.
5. + T cell help. J. Exp. Med. 1997. 186: 65-70.
6. + T lymphocytes. Nature 2003. 421: 852-856.
7. Shedlock, D. J. and Shen, H., Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003. 300: 337-339.
8. Sun, J. C. and Bevan, M. J., Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003. 300: 339-342.
9. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R. and Melief, C. J., T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998. 393: 480-483.
10. Diehl, L., den Boer, A. T., Schoenberger, S. P., van der Voort, E. I., Schumacher, T. N., Melief, C. J., Offringa, R. and Toes, R. E., CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat. Med. 1999. 5: 774-779.
11. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. and Alber, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 1996. 184: 747-752.
12. Schuurhuis, D. H., Laban, S., Toes, R. E., Ricciardi-Castagnoli, P., Kleijmeer, M. J., van der Voort, E. I., Rea, D. et al., Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J. Exp. Med. 2000. 192: 145-150.
13. + T cell activation by CD4+CD25+ immunoregulatory cells. J. Immunol. 2001. 167: 1137-1140.
14. Sutmuller, R. P., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N., Wildenberg, M. E., Allison, J. P., Toes, R. E. et al., Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. 2001. 194: 823-832.
15. Antony, P. A., Piccirillo, C. A., Akpinarli, A., Finkelstein, S. E., Speiss, P. J., Surman, D. R., Palmer, D. C. et al., CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J. Immunol. 2005. 174: 2591-2601.
16. den Haan, J. M., Kraal, G. and Bevan, M. J., Cutting edge: Lipopolysaccharide induces IL-10-producing regulatory CD4+ T cells that suppress the CD8+ T cell response. J. Immunol. 2007. 178: 5429-5433.
17. Gonzalez, A., Andre-Schmutz, I., Carnaud, C., Mathis, D. and Benoist, C., Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes. Nat. Immunol. 2001. 2: 1117-1125.
18. Langenkamp, A., Messi, M., Lanzavecchia, A. and Sallusto, F., Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 2000. 1: 311-316.
19. Schuurhuis, D. H., Ioan-Facsinay, A., Nagelkerken, B., van Schip, J. J., Sedlik, C., Melief, C. J., Verbeek, J. S. and Ossendorp, F., Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J. Immunol. 2002. 168: 2240-2246.
20. Charbonnier, L. M., van Duivenvoorde, L. M., Apparailly, F., Cantos, C., Han,W. G., Noel, D., Duperray, C. et al., Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells. J. Immunol. 2006. 177: 3806-3813.
21. Hussell, T. and Openshaw, P. J., Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection. J. Gen. Virol. 1998. 79: 2593-2601.
22. Billerbeck, E., Blum, H. E. and Thimme, R., Parallel expansion of human virus-specific Foxp3- effector memory and de novo-generated Foxp3+ regulatory CD8+ T cells upon antigen recognition in vitro. J. Immunol. 2007. 179: 1039-1048.
23. Joosten, S. A., van Meijgaarden, K. E., Savage, N. D., de Boer, T., Triebel, F., van der, W. A., deHeer, E. et al., Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc. Natl. Acad. Sci. USA 2007. 104: 8029-8034.
24. Kiniwa, Y., Miyahara, Y., Wang, H. Y., Peng, W., Peng, G., Wheeler, T. M., Thompson, T. C. et al., CD8+ Foxp31 regulatory T cells mediate immunosuppression in prostate cancer. Clin. Cancer Res. 2007. 13: 6947-6958.
25. Mahic, M., Henjum, K., Yaqub, S., Bjornbeth, B.A., Torgersen, K.M., Tasken, K. and Aandahl, E. M., Generation of highly suppressive adaptive CD8(+)CD25(+)FOXp3(+) regulatory T cells by continuous antigen stimulation. Eur. J. Immunol. 2008. 38: 640-646.
26. Ben David, H., Sharabi, A., Dayan, M., Sela, M. and Mozes, E., The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand. Proc. Natl. Acad. Sci. USA 2007. 104: 17459-17464.
27. Fan, T. M., Kranz, D. M., Flavell, R. A. and Roy, E. J., Costimulatory strength influences the differential effects of transforming growth factor beta1 for the generation of CD8(+) regulatory T cells. Mol. Immunol. 2008. 45: 2937-2950.
28. Celluzzi, C. M., Mayordomo, J. I., Storkus, W. J., Lotze, M. T. and Falo, L. D., Jr., Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 1996. 183: 283-287.
29. Brossart, P., Goldrath, A.W., Butz, E. A., Martin, S. and Bevan, M. J., Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 1997. 158: 3270-3276.
30. Reuter, T., Heldmann, M., Schimmer, S., Schepers, K. and Dittmer, U., Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells. Vaccine 2004. 22: 2686-2689.
31. Nakamura, M., Iwahashi, M., Nakamori, M., Ueda, K., Ojima, T., Naka, T., Ishida, K., and Yamaue, H., Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: Comparison with immunodominant peptide-pulsed DCs. Oncology 2005. 68: 163-170.
32. Paglia, P., Chiodoni, C., Rodolfo, M. and Colombo, M. P., Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 1996. 183: 317-322.
33. Ito, F., Li, Q., Shreiner, A. B., Okuyama, R., Jure-Kunkel, M. N., Teitz-Tennenbaum, S. and Chang, A. E., Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines. Cancer Res. 2004. 64: 8411-8419.
34. Toes, R. E., van der Voort, E. I., Schoenberger, S. P., Drijfhout, J. W., van Bloois, L., Storm, G., Kast, W. M. et al., Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J. Immunol. 1998. 160: 4449-4456.
35. Porgador, A. and Gilboa, E., Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 1995. 182: 255-260.
36. Serody, J. S., Collins, E. J., Tisch, R. M., Kuhns, J. J. and Frelinger, J. A., T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery. J. Immunol. 2000. 164: 4961-4967.
37. Okada, N., Tsujino, M., Hagiwara, Y., Tada, A., Tamura, Y., Mori, K., Saito, T. et al., Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens. Br. J. Cancer 2001. 84: 1564-1570.
38. Arase, H., Saito, T., Phillips, J. H. and Lanier, L. L., Cutting edge: The mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J. Immunol. 2001. 167: 1141-1144.
39. Rahmoun, M., Foussat, A., Groux, H., Pene, J., Yssel, H. and Chanez, P., Enhanced frequency of. Int. Arch. Allergy Immunol. 2006. 140: 139-149.
40. Kassiotis, G., Gray, D., Kiafard, Z., Zwirner, J. and Stockinger, B., Functional specialization of memory Th cells revealed by expression of integrin CD49b. J. Immunol. 2006. 177: 968-975.
41. Kambayashi, T., Assarsson, E., Chambers, B. J. and Ljunggren, H. G., Expression of the DX5 antigen on CD81 T cells is associated with activation and subsequent cell death or memory during influenza virus infection. Eur. J. Immunol. 2001. 31: 1523-1530.
42. Matyszak, M. K., Citterio, S., Rescigno, M. and Ricciardi-Castagnoli, P., Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur. J. Immunol. 2000. 30: 1233-1242.
43. Winzler, C., Rovere, P., Rescigno, M., Granucci, F., Penna, G., Adorini, L., Zimmermann, V. S. et al., Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 1997. 185: 317-328.